https://azuraophthalmics.com

Azura OphthalmicsAzura Ophthalmics Skip to content About Us Menu Toggle Who We Are Our Leadership Our Team Our Board of Directors Our Scientific Advisors Our Investors Science Menu Toggle Role of Keratolytics in Ophthalmology Publications Programs Menu Toggle Our Strategy R&D Pipeline Clinical Trials Patients News and Events Menu Toggle Press Releases Events Media Careers Main Menu About Us Menu Toggle Who We Are Our Leadership Our Team Our Board of Directors Our Scientific Advisors Our Investors Science Menu Toggle Role of Keratolytics in Ophthalmology Publications Programs Menu Toggle Our Strategy R&D Pipeline Clinical Trials Patients News and Events Menu Toggle Press Releases Events Media Careers About Us Menu Toggle Who We Are Our Leadership Our Team Our Board of Directors Our Scientific Advisors Our Investors Science Menu Toggle Role of Keratolytics in Ophthalmology Publications Programs Menu Toggle Our Strategy R&D Pipeline Clinical Trials Patients News and Events Menu Toggle Press Releases Events Media Careers Main Menu About Us Menu Toggle Who We Are Our Leadership Our Team Our Board of Directors Our Scientific Advisors Our Investors Science Menu Toggle Role of Keratolytics in Ophthalmology Publications Programs Menu Toggle Our Strategy R&D Pipeline Clinical Trials Patients News and Events Menu Toggle Press Releases Events Media Careers We’ve set our sights on harnessing the unique properties of keratolytics to revolutionize the treatment of ophthalmic conditions Delivering First-in-ClassOphthalmic Keratolytics About Us Highly Differentiated Approach Combines Ophthalmologic and Dermatologic Solutions to Harness the Unique Properties of Keratolytics to Treat the Root Cause of Underserved Ocular Indications Science Addressing the Full Spectrum of Unmet Patient Needs in Lid Margin and Ocular Surface Diseases Programs Latest News Azura Ophthalmics Announces Participation at the 2023 SVB Securities Global Biopharma Conference January 17, 2023 Read WE'VE SET OUR SIGHTS ON HARNESSING THE UNIQUE PROPERTIES OF KERATOLYTICS TO TREAT OCULAR SURFACE CONDITIONS Connect with us: info@azuraophthalmics.com 5 Druyanov Street Tel Aviv, Israel 6314305 +972 3 647 5312 © 2024 All Rights Reserved Terms of Use Privacy Policy References Scroll to Topenusen-US1730682817https://azuraophthalmics.com

დაარედაქტირე შენი საიტი?

რას აკეთებ?